Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Coaldale › NPI 1437182847
Hospital

The Carbon-Schuylkill Community Hospital, INC.

The Carbon-Schuylkill Community Hospital, INC. was paid $8.59M by Medicaid between Jan 2019 and Dec 2024, across 187 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 18% of everything it billed.

33Billing provider infoTHE CARBON-SCHUYLKILL COMMUNITY HOSPITAL, INC.
COALDALE, PA 18218
33aNPI1437182847assigned 07/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.59M
24GClaims197,622
24DCodes billed187
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#40 of 154
Median peer was paid$2.82M
This provider vs. median3.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20194,165$335K
202018,369$739K
202168,286$2.39M
202233,343$1.65M
202343,559$2.05M
2024incomplete29,900$1.42M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 18% 18,957 17,880 $1.55M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 17% 15,318 14,871 $1.46M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 13% 8,898 8,624 $1.10M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 6.5% 5,194 5,062 $558K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 6.2% 14,544 4,233 $531K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.1% 3,188 3,039 $523K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 4.8% 3,708 3,706 $409K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2.7% 4,162 3,981 $232K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.3% 2,538 2,469 $195K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.2% 1,110 1,078 $187K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2.0% 1,500 1,478 $169K
G0378 Hospital observation service, per hour 1.6% 177 161 $141K
175 more codes
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.4% 2,597 $118K
80053 Comprehensive metabolic panel 1.1% 9,509 $94K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.1% 2,702 $92K
80050 General health panel <1% 2,030 $83K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 12,048 $61K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 5,770 $61K
S9083 Global fee urgent care centers <1% 594 $59K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,459 $54K
80061 Lipid panel <1% 3,317 $42K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 2,885 $42K
71275 Computed tomographic angiography, chest, with contrast material <1% 215 $41K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 5,879 $39K
97162 <1% 526 $35K
97161 <1% 444 $31K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 480 $29K
87070 <1% 4,094 $29K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 124 $28K
70450 Computed tomography, head or brain; without contrast material <1% 465 $28K
71045 Radiologic examination, chest; single view <1% 3,613 $27K
X0620 <1% 136 $26K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 242 $21K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 266 $20K
84443 Thyroid stimulating hormone (TSH) <1% 943 $19K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,393 $18K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 226 $17K
80048 Basic metabolic panel (calcium, ionized) <1% 2,138 $17K
77067 Screening mammography, bilateral, including computer-aided detection <1% 188 $16K
83690 <1% 3,080 $13K
71046 Radiologic examination, chest; 2 views <1% 962 $12K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 458 $12K
83880 <1% 441 $11K
73630 <1% 975 $11K
99204 Doctor's office visit, new patient (more involved) <1% 77 $10K
72125 Computed tomography, cervical spine; without contrast material <1% 158 $10K
73610 <1% 539 $10K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 142 $9K
83735 <1% 1,562 $9K
81001 <1% 2,874 $8K
87631 <1% 55 $8K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 145 $7K
83036 Hemoglobin; glycosylated (A1C) <1% 1,094 $7K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 24 $7K
86803 <1% 372 $7K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 196 $6K
87040 <1% 290 $5K
73564 <1% 258 $5K
84702 <1% 318 $5K
82728 <1% 488 $5K
73562 <1% 366 $5K
97164 <1% 152 $5K
84484 <1% 912 $5K
85610 <1% 1,558 $5K
73030 <1% 363 $5K
71250 <1% 91 $5K
85379 <1% 541 $5K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 130 $5K
85730 <1% 830 $5K
84439 <1% 623 $5K
83605 <1% 689 $5K
73130 <1% 386 $4K
84153 <1% 213 $4K
99050 <1% 40 $4K
77063 Screening digital breast tomosynthesis, bilateral <1% 188 $4K
82607 <1% 338 $4K
82570 <1% 549 $4K
85027 <1% 599 $4K
97163 <1% 61 $4K
80076 <1% 482 $4K
83540 <1% 469 $4K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 149 $3K
87186 <1% 447 $3K
81002 <1% 1,024 $3K
72110 <1% 153 $3K
73110 <1% 291 $3K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 17 $3K
82043 <1% 449 $3K
73502 <1% 176 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 136 $3K
87077 <1% 439 $3K
82805 <1% 92 $3K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 13 $3K
82784 <1% 146 $3K
94729 <1% 95 $3K
93971 <1% 41 $3K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 193 $2K
86618 <1% 111 $2K
81003 <1% 912 $2K
92567 <1% 183 $2K
86003 <1% 12 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 40 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 110 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,403 $2K
83550 <1% 440 $2K
87147 <1% 624 $2K
70486 <1% 24 $2K
94727 <1% 95 $2K
90715 <1% 146 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 616 $2K
76770 <1% 43 $2K
86140 <1% 493 $1K
96367 <1% 79 $1K
86038 <1% 89 $1K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 18 $1K
82746 <1% 106 $1K
92557 <1% 41 $1K
84403 <1% 44 $1K
83970 <1% 31 $1K
72050 <1% 43 $1K
86850 <1% 151 $1K
87522 Neg quan hep c or qual rna <1% 25 $1K
87430 <1% 158 $995.40
85652 <1% 325 $864.25
84145 <1% 50 $817.17
73080 <1% 75 $762.20
86901 <1% 201 $709.71
86900 <1% 202 $705.90
87340 <1% 57 $691.12
82550 <1% 108 $639.35
97168 <1% 13 $623.87
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,703 $604.42
86255 <1% 30 $560.44
82948 <1% 272 $495.60
73590 <1% 34 $493.93
83721 <1% 45 $487.89
94060 <1% 50 $484.92
85007 <1% 133 $484.20
84144 <1% 28 $475.66
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,697 $413.90
J2270 Injection, morphine sulfate, up to 10 mg <1% 266 $399.40
86430 <1% 59 $382.57
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 13 $369.96
84100 <1% 76 $339.31
84550 <1% 57 $320.39
86706 <1% 28 $315.96
86704 <1% 27 $310.40
74018 <1% 27 $304.72
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,523 $281.45
84146 <1% 14 $276.90
72100 <1% 13 $263.38
J7050 Infusion, normal saline solution, 250 cc <1% 326 $239.07
82947 <1% 55 $213.53
83001 <1% 12 $213.15
94010 <1% 28 $204.41
84156 <1% 58 $196.84
73140 <1% 19 $169.08
J1170 Injection, hydromorphone, up to 4 mg <1% 621 $162.54
300 Patient transfer system <300 <1% 37 $161.97
83655 <1% 15 $160.80
36415 Collection of venous blood by venipuncture <1% 763 $159.57
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 14 $158.61
83525 <1% 13 $132.00
J3475 Injection, magnesium sulfate, per 500 mg <1% 558 $121.58
J3010 Injection, fentanyl citrate, 0.1 mg <1% 642 $112.95
87205 <1% 29 $105.48
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 54 $101.00
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 686 $83.43
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 798 $71.47
86592 <1% 13 $50.16
96375 Therapeutic injection; each additional sequential IV push <1% 14 $49.76
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 17 $21.67
81025 <1% 43 $20.00
J2060 Injection, lorazepam, 2 mg <1% 30 $7.29
94760 <1% 15 $1.14
J2704 Injection, propofol, 10 mg 0% 540 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 44 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 0% 42 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 29 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 14 $0.00
88305 Level IV - Surgical pathology, gross and microscopic examination 0% 13 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 94 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 39 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 26 $0.00
J1756 Injection, iron sucrose, 1 mg 0% 163 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 38 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 31 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROSKO, ANDREA (ECECUTIVE DIRECTOR, SLPHO)
Same official

Other billing entities under ROSKO, ANDREA

Full network →
ProviderLocationPaid
ST. Luke's HospitalAllentown, PA$23.43M
The Carbon-Schuylkill Community Hospital, INC.Nesquehoning, PA$433K
ST. Luke's HospitalBethlehem, PA$3K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.